These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 8836862

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
    Peros E, Geroldi D, D'Angelo A, Falcone C, Montagna L, Carabela M, Emanuele E.
    Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
    [Abstract] [Full Text] [Related]

  • 3. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C, Garzaniti A, Buscaglia P, Bonetti G, Falcone C, Fratino P, Finardi G, Geroldi D.
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G.
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A, Castaldo M, Sardo A, Cinquegrani M, Bonaiuto M, Zema M, Gravina M, Mangano C.
    Minerva Med; 1999 Mar; 90(5-6):151-8. PubMed ID: 10780189
    [Abstract] [Full Text] [Related]

  • 7. [Apolipoprotein(a) phenotypes as markers of genetic susceptibility for cardiovascular risk in occupational medicine].
    Mennoia NV, Gazzaruso C, Geroldi D, Candura SM.
    G Ital Med Lav Ergon; 1999 Mar; 21(3):206-17. PubMed ID: 10771732
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
    Liu X, Sun L, Li Z, Gao Y, Hui R.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1396-400. PubMed ID: 12509922
    [Abstract] [Full Text] [Related]

  • 10. Concentrations of the atherogenic Lp(a) are elevated in FH.
    Lingenhel A, Kraft HG, Kotze M, Peeters AV, Kronenberg F, Kruse R, Utermann G.
    Eur J Hum Genet; 1998 Jan 25; 6(1):50-60. PubMed ID: 9781014
    [Abstract] [Full Text] [Related]

  • 11. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
    Emanuele E, Peros E, Minoretti P, Falcone C, D'Angelo A, Montagna L, Geroldi D.
    BMC Cardiovasc Disord; 2003 Dec 12; 3():12. PubMed ID: 14670093
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J, Silversides C, Dembinski TC, Chan MC, Tate R, Dick A, Nixon P, Ren S, Shen GX.
    Clin Invest Med; 2002 Jun 12; 25(3):74-82. PubMed ID: 12137255
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
    Shen GX, Mymin D, Dembinski T, Krahn A, Angel A.
    Clin Invest Med; 1995 Feb 12; 18(1):33-41. PubMed ID: 7768064
    [Abstract] [Full Text] [Related]

  • 14. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P.
    J Clin Invest; 1993 Feb 12; 91(2):397-401. PubMed ID: 8432847
    [Abstract] [Full Text] [Related]

  • 15. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
    Emanuele E, Peros E, Minoretti P, D'Angelo A, Montagna L, Falcone C, Geroldi D.
    Clin Chim Acta; 2004 Dec 12; 350(1-2):159-65. PubMed ID: 15530473
    [Abstract] [Full Text] [Related]

  • 16. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
    Gazzaruso C, Garzaniti A, Geroldi D, Finardi G.
    Cardiologia; 1999 Apr 12; 44(4):347-54. PubMed ID: 10371786
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
    Peros E, Geroldi D, Bugatti S, Caporali R, Rossi P, Montecucco C, D'Angelo A, Emanuele E.
    Int J Mol Med; 2005 Apr 12; 15(4):661-5. PubMed ID: 15754029
    [Abstract] [Full Text] [Related]

  • 18. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P.
    Nephrol Dial Transplant; 1995 Apr 12; 10(1):75-81. PubMed ID: 7724034
    [Abstract] [Full Text] [Related]

  • 19. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B, Lupattelli G, Siepi D, Bianchi A, Anniboletti PF, Blandini V, Sinzinger H, Mannarino E, Palumbo R.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):987-91. PubMed ID: 12635466
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.